Details for 2016804054

Up to date per 03.04.2026

Actions

Title / Product Name

KOMBINATION AUS EINEM PD-1-ANTAGONISTEN UND CPG-C-TYP-OLIGONUKLEOTID ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016804054

EP Publication Number

3302501

E-Number

1431770

Language

PCT Number

US16034275

Publication Date

11.04.2018 A

22.09.2021 B1

Registration Date

22.09.2021

AT Publication Date

15.10.2021

Application Date

26.05.2016

Registration Number

Priorities

29.05.2015

201562168449 P

01.06.2015

201562169309 P

IPC

A61K 31/7115 20060101AFI20190122BHEP

Maximum Duration of Protection

26.05.2036

Owner

Merck Sharp & Dohme Corp.126 East Lincoln Avenue Rahway, NJ 07065-0907US

Surefire Medical, Inc.d/b/a TriSalus Life Sciences 6272 West 91st Avenue Westminster, CO 80031US

Representative

No representatives present

Inventor

YU, Ying901 S. California Avenue Palo Alto, California 94304US

DENKER, Andrew Evan119 Bleddyn Road Ardmore, PA 19003US

SADEKOVA, Svetlana901 S. California Avenue Palo Alto, California 94304US

PHAN, Uyen Truong901 S. California Avenue Palo Alto, California 94304US

KASTELEIN, Robert A.901 S. California Avenue Palo Alto, California 94304US

KAUFMAN, David Ross351 N. Sumneytown Pike North Wales, Pennsylvania 19454US

COFFMAN, Robert L.2929 Seventh Street, Suite 100 Berkeley, California 94710-2753US

GUIDUCCI, Cristiana2929 Seventh Street, Suite 100 Berkeley, California 94710-2753US

JANSSEN, Robert S.2929 Seventh Street, Suite 100 Berkeley, California 94710-2753US